28.34
price down icon0.25%   -0.07
after-market  After Hours:  28.34 
loading

Integra Lifesciences Holdings Corp Stock (IART) Forecast

The Integra Lifesciences Holdings Corp (IART) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $51.94, representing a +83.28% increase from the current price of $28.34. The highest analyst price target is $54.16, and the lowest is $49.72.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IART Price Target
Average 55.61 (+96.22% Upside)
loading

Is Integra Lifesciences Holdings Corp (IART) A Buy Now?

Oscillators
Name Value Action
RSI(14) 22.75 Buy
STOCH(9,6) 20.91 Neutral
STOCHRSI(14) 13.50 Buy
MACD(12,26) -1.9045 Sell
ADX(14) 47.45 Sell
William %R -84.76 Buy
CCI(14) -95.62 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
30.06
Sell
29.97
Sell
MA20
31.98
Sell
31.48
Sell
MA50
35.52
Sell
34.51
Sell
MA100
38.90
Sell
37.01
Sell
MA200
39.61
Sell
40.49
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, IART could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on IART, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 22.75 indicates that IART is oversold. This indicates that IART price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 20.91 indicates that IART is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.5 indicates that IART is oversold. This suggests that IART price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 47.45 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -95.62 indicates that IART is still oversold but not to an extreme extent.

Long-term IART price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Integra Lifesciences Holdings Corp financial reports and earnings history, Integra Lifesciences Holdings Corp (IART) stock could reach $53.89 by 2030, $57.69 by 2040 and $70.05 by 2050. See the projected annual prices until 2050 of the Integra Lifesciences Holdings Corp stock below:

  • Integra Lifesciences Holdings Corp (IART) is expected to reach an average price of $34.27 in 2035, with a high prediction of $39.40 and a low estimate of $33.50. This indicates an $20.92% rise from the last recorded price of $28.34.
  • Integra Lifesciences Holdings Corp (IART) stock is projected to chart a bullish course in 2040, with an average price target of $55.04, representing an $94.21% surge from its current level. The forecast ranges from a conservative $52.22 to a sky-high $57.69.
  • Our analysts predict Integra Lifesciences Holdings Corp (IART) to jump 68.77% by 2045, soaring from $47.17 to an average price of $47.83, potentially reaching $57.92. While $47.17 is the low estimate, the potential upside is significant.
  • Integra Lifesciences Holdings Corp (IART) stock is expected to climb by 2050, reaching an average of $64.86, a $128.86% jump from its current level. However, a wide range of estimates exists, with high and low targets of $70.05 and $61.95, respectively, highlighting the market's uncertainty.

Integra Lifesciences Holdings Corp Stock (IART) Year by Year Forecast

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2024

Our forecast for IART stock price in 2024 now indicates an average price target of $53.64 with a high forecast of $65.12 and a low forecast of $42.17. The average prediction reflects an increase of +89.29% from the last recorded price of $28.34.
Month Average Low High Change from today's price
May, 2024 $52.72 $49.72 $54.16 +86.03%
June, 2024 $46.64 $46.34 $53.30 +64.57%
July, 2024 $54.84 $46.10 $56.63 +93.51%
August, 2024 $63.83 $52.04 $65.12 +125.23%
September, 2024 $59.96 $58.51 $64.30 +111.57%
October, 2024 $59.38 $58.40 $64.16 +109.53%
November, 2024 $62.72 $57.84 $62.91 +121.31%
December, 2024 $58.49 $54.74 $62.91 +106.39%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2025

Integra Lifesciences Holdings Corp Stock (IART) is expected to reach an average price of $48.75 in 2025, with a high prediction of $63.26 and a low estimate of $34.24. This indicates an +72.02% rise from the last recorded price of $28.34.
Month Average Low High Change from today's price
January, 2025 $61.61 $57.75 $62.78 +117.40%
February, 2025 $57.34 $56.83 $63.26 +102.33%
March, 2025 $57.93 $53.82 $60.76 +104.41%
April, 2025 $49.76 $48.35 $61.75 +75.58%
May, 2025 $44.23 $34.24 $48.70 +56.07%
June, 2025 $51.08 $40.89 $51.73 +80.24%
July, 2025 $49.99 $45.88 $53.28 +76.38%
August, 2025 $49.32 $46.92 $56.30 +74.03%
September, 2025 $49.84 $45.32 $50.61 +75.86%
October, 2025 $51.28 $46.85 $53.13 +80.95%
November, 2025 $45.66 $44.94 $51.66 +61.12%
December, 2025 $47.26 $42.98 $48.54 +66.76%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2026

The predicted value for Integra Lifesciences Holdings Corp (IART) in 2026 is set at an average of $59.79. Estimates vary from a peak of $77.43 to a trough of $42.15, indicating an +110.97% surge from the present price of $28.34.
Month Average Low High Change from today's price
January, 2026 $44.13 $42.15 $52.17 +55.72%
February, 2026 $55.65 $43.74 $56.90 +96.37%
March, 2026 $66.42 $53.09 $66.60 +134.37%
April, 2026 $69.33 $62.38 $70.70 +144.64%
May, 2026 $68.25 $65.14 $71.37 +140.83%
June, 2026 $68.86 $64.53 $71.18 +142.98%
July, 2026 $72.28 $65.35 $72.53 +155.05%
August, 2026 $70.32 $69.41 $77.43 +148.13%
September, 2026 $68.75 $65.96 $71.66 +142.59%
October, 2026 $68.47 $67.03 $71.28 +141.60%
November, 2026 $71.06 $64.61 $73.38 +150.74%
December, 2026 $75.92 $70.21 $76.73 +167.89%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Integra Lifesciences Holdings Corp (IART) is $63.89, with a high forecast of $76.53 and a low forecast of $51.24. This indicates an +125.42% increase from the last price of $28.34.
Month Average Low High Change from today's price
January, 2027 $68.51 $67.99 $76.53 +141.74%
February, 2027 $70.85 $65.89 $72.88 +150.00%
March, 2027 $64.89 $64.68 $75.01 +128.97%
April, 2027 $65.84 $61.88 $67.55 +132.32%
May, 2027 $66.60 $63.42 $69.98 +135.00%
June, 2027 $65.64 $61.83 $67.43 +131.62%
July, 2027 $67.58 $61.53 $68.18 +138.46%
August, 2027 $66.55 $62.64 $68.32 +134.83%
September, 2027 $61.19 $59.81 $66.54 +115.91%
October, 2027 $62.18 $55.19 $62.42 +119.41%
November, 2027 $54.52 $53.60 $63.02 +92.38%
December, 2027 $53.04 $51.24 $56.39 +87.16%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2028

In 2028, Integra Lifesciences Holdings Corp (IART) is projected to reach an average price of $49.06, with a high projection of $60.72 and a low estimate of $37.39. This indicates an +73.09% rise from the last price of $28.34.
Month Average Low High Change from today's price
January, 2028 $54.00 $52.86 $57.83 +90.54%
February, 2028 $49.62 $46.49 $53.85 +75.09%
March, 2028 $43.04 $41.90 $50.46 +51.87%
April, 2028 $50.28 $40.70 $50.80 +77.42%
May, 2028 $54.97 $47.70 $55.03 +93.97%
June, 2028 $56.32 $54.08 $59.71 +98.73%
July, 2028 $58.26 $53.98 $59.25 +105.58%
August, 2028 $57.57 $56.10 $60.72 +103.14%
September, 2028 $52.90 $52.16 $57.63 +86.66%
October, 2028 $59.01 $52.33 $59.36 +108.22%
November, 2028 $49.08 $48.93 $59.33 +73.18%
December, 2028 $38.97 $37.39 $50.81 +37.51%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2029

The 2029 price forecast for Integra Lifesciences Holdings Corp Stock (IART) is $45.51 on average, with a high prediction of $57.54 and a low estimate of $33.47. This represents an +60.57% increase from the previous price of $28.34.
Month Average Low High Change from today's price
January, 2029 $40.26 $39.37 $42.23 +42.06%
February, 2029 $45.50 $40.12 $46.78 +60.55%
March, 2029 $41.62 $41.04 $45.68 +46.86%
April, 2029 $38.59 $38.22 $44.24 +36.17%
May, 2029 $37.97 $37.26 $39.37 +33.98%
June, 2029 $36.19 $33.47 $39.09 +27.70%
July, 2029 $41.30 $36.19 $42.52 +45.73%
August, 2029 $45.16 $40.39 $45.30 +59.35%
September, 2029 $46.72 $42.20 $48.24 +64.86%
October, 2029 $54.94 $45.68 $57.06 +93.86%
November, 2029 $56.07 $53.95 $57.37 +97.85%
December, 2029 $51.19 $49.87 $57.54 +80.63%

Integra Lifesciences Holdings Corp Stock (IART) Price Forecast for 2030

Integra Lifesciences Holdings Corp Stock (IART) is expected to reach an average price of $52.47 in 2030, with a high forecast of $65.15 and a low forecast of $39.79. This signifies an +85.14% surge from the last price of $28.34.
Month Average Low High Change from today's price
January, 2030 $52.60 $49.75 $53.89 +85.60%
February, 2030 $49.45 $46.13 $51.79 +74.49%
March, 2030 $54.87 $49.29 $56.66 +93.61%
April, 2030 $62.51 $52.07 $65.15 +120.57%
May, 2030 $59.99 $58.54 $63.39 +111.68%
June, 2030 $59.41 $58.43 $64.19 +109.63%
July, 2030 $55.79 $54.77 $62.94 +96.86%
August, 2030 $58.52 $55.90 $59.29 +106.49%
September, 2030 $59.09 $57.78 $63.29 +108.50%
October, 2030 $58.01 $55.90 $59.82 +104.69%
November, 2030 $57.96 $53.85 $60.79 +104.52%
December, 2030 $42.13 $39.79 $61.78 +48.66%
medical_devices PHG
$21.07
price up icon 1.69%
medical_devices STE
$203.90
price up icon 1.17%
$309.02
price down icon 0.48%
medical_devices ZBH
$119.35
price down icon 0.33%
$124.34
price down icon 9.91%
medical_devices EW
$86.43
price down icon 1.80%
Cap:     |  Volume (24h):